Correlation Between Inhibrx and Adicet Bio
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Adicet Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Adicet Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Adicet Bio, you can compare the effects of market volatilities on Inhibrx and Adicet Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Adicet Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Adicet Bio.
Diversification Opportunities for Inhibrx and Adicet Bio
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inhibrx and Adicet is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Adicet Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adicet Bio and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Adicet Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adicet Bio has no effect on the direction of Inhibrx i.e., Inhibrx and Adicet Bio go up and down completely randomly.
Pair Corralation between Inhibrx and Adicet Bio
Given the investment horizon of 90 days Inhibrx is expected to generate 0.58 times more return on investment than Adicet Bio. However, Inhibrx is 1.72 times less risky than Adicet Bio. It trades about -0.03 of its potential returns per unit of risk. Adicet Bio is currently generating about -0.06 per unit of risk. If you would invest 1,580 in Inhibrx on September 2, 2024 and sell it today you would lose (54.00) from holding Inhibrx or give up 3.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Adicet Bio
Performance |
| Timeline |
| Inhibrx |
| Adicet Bio |
Inhibrx and Adicet Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Adicet Bio
The main advantage of trading using opposite Inhibrx and Adicet Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Adicet Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adicet Bio will offset losses from the drop in Adicet Bio's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Adicet Bio vs. Edgewise Therapeutics | Adicet Bio vs. Cullinan Oncology LLC | Adicet Bio vs. Vor Biopharma | Adicet Bio vs. Tenaya Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |